ClinicalTrials.gov
ClinicalTrials.gov Menu

A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01607294
Recruitment Status : Completed
First Posted : May 30, 2012
Last Update Posted : September 11, 2015
Sponsor:
Information provided by (Responsible Party):
Esperion Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2012
  Actual Study Completion Date : October 2012
  Certification/Extension First Submitted : August 13, 2015